Citation: | Jie LIU, Yi XIAO. Wegener's Granulomatosis Combined with Pulmonary Tuberculosis: Report of 8 Cases and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 167-170. |
[1] |
Cordier JF, Valeyre D, Guillevin L.Pulmonary Wegener's granulomatosis:a clinical and imaging study of 77 cases[J]. Chest, 1990, 97:906-912. DOI: 10.1378/chest.97.4.906
|
[2] |
Duna GF, Galperin C, Hoffman GS.Wegener's granulomatosis[J]. Rheum Dis Clin North Am, 1995, 21:949-986. https://pubmed.ncbi.nlm.nih.gov/14968341/
|
[3] |
Hagen EC, Daha MR, Hermans J, et al.Diagnostic value of standandized assays for anti-neutrophil cytoplasmic antibodies in idiopathicsy stemic vasculitis.EC/BCR Project for ANCA Assay Standardization[J]. Kidney Int, 1998, 53:743-753. DOI: 10.1046/j.1523-1755.1998.00807.x
|
[4] |
Pradhan VD, Badakere SS, Ghosh K, et al.Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis [J]. Indian J MedSci, 2004, 58:283-288. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=81391c72a549c8b1d5961370edf4b209
|
[5] |
Flores-Suárez LF, Cabiedes J, Villa AR, et al.Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis[J]. Rheumatology, 2003, 42:223-229. DOI: 10.1093/rheumatology/keg066
|
[6] |
Esquivel-Valerio JA, Flores-Suárez LF, Rodríguez-Amado J, et al, Antineutrophil cytoplasm autoantibodies inpatients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation [J]. Clin Exp Rheumatol, 2010, 28(1 Suppl57):35-39. http://www.ncbi.nlm.nih.gov/pubmed/20412700/
|
[7] |
Stone JH, Merkel PA, Spiera R, et al.Rituximab versus cyclophosphamide for ANCA-associated vasculitis[J]. N Engl J Med, 2010, 363:221-232. DOI: 10.1056/NEJMoa0909905
|
[8] |
Toyoshima M, Chida K, Suda T, et al.Wegener's granulomatosis responding to antituberculous drugs[J]. Chest, 2001, 119:643-645. DOI: 10.1378/chest.119.2.643
|
[1] | WANG Shuo, DENG Yuntian, PENG Huan, ZHANG Xiangfeng. Progress in the Treatment of Non-small Cell Lung Cancer with Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 409-415. DOI: 10.12290/xhyxzz.2022-0151 |
[2] | DAI Liyuan, SHI Yuankai, HAN Xiaohong. Advances in Dynamic Monitoring of Immune Checkpoint Inhibitors as the Prognostic Markers for Advanced Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 287-295. DOI: 10.12290/xhyxzz.2021-0608 |
[3] | WU Li'na, GAO Yi, LI Wosong, LIU Yong, QIN Xiaosong. Application Value of Serum Kreb Von Den Lungen-6 in the Adjuvant Treatment of Lung Injury after Non-small Cell Lung Cancer Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 496-502. DOI: 10.12290/xhyxzz.2021-0308 |
[4] | LI Guo-yu, HE Ming. Research Progress of Targeted Therapy at Rare Targets for Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 268-274. DOI: 10.3969/j.issn.1674-9081.2020.00.019 |
[5] | Lei LIU, Jia-qi ZHANG, Gui-ge WANG, Cheng HUANG, Li LI, Nai-xin LIANG, Shan-qing LI. Fibroblast Growth Factor Receptor 1 in Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 666-672. DOI: 10.3969/j.issn.1674-9081.2019.06.020 |
[6] | Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015 |
[7] | Xiao-na JIN, Nai-xin LIANG, Meng-zhao WANG, Bing JIA, Xi-min SHI, Shan-qing LI, Fang LI, Fan WANG, Zhao-hui ZHU. Integrin Receptor Imaging 99mTc-3PRGD2 SPECT/CT in Diagnosis and Lymph Node Staging of Non-Small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(5): 327-333. DOI: 10.3969/j.issn.1674-9081.2016.05.002 |
[8] | Xiao-hua SHI, Sha-fei WU, Qing LING, Zhen HUO, Zhi-yong LIANG. Clinicopathological Features and Immunohistochemical Phenotypes of Adenoid Cystic Carcinoma of the Uterine Cervix[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 197-201. DOI: 10.3969/j.issn.1674-9081.2015.03.007 |
[9] | Nai-xin LIANG, Ya-xin LIU, Lei LIU, Shan-qing LI. Co-mutation of PIK3CA and Other Oncogenes in Patients with Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 186-190. DOI: 10.3969/j.issn.1674-9081.2015.03.005 |
[10] | Xiao-hua SHI, Zhi-yong LIANG, Huan-wen WU, Xin-yu REN, Tong-hua LIU. Effect of RNA Interference Plasmid on the Expression of Oncogene AKT2 in Pancreatic Cancer Cell Line Panc-1[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 102-108. DOI: 10.3969/j.issn.1674-9081.2012.01.021 |